ACT-660602
oral CXCR3 antagonist efficacy in mice model of lung inflammation from HTS and opt J. Med. Chem. Idorsia Pharmaceuticals Ltd., Allschwil, CH
Molecules of the Month - August 2022
oral CXCR3 antagonist efficacy in mice model of lung inflammation from HTS and opt J. Med. Chem. Idorsia Pharmaceuticals Ltd., Allschwil, CH
Molecules of the Month - August 2022